{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:16:04Z","timestamp":1772244964041,"version":"3.50.1"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T00:00:00Z","timestamp":1337817600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1002717","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T17:11:06Z","timestamp":1337879466000},"page":"e1002717","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":84,"title":["Chitohexaose Activates Macrophages by Alternate Pathway through TLR4 and Blocks Endotoxemia"],"prefix":"10.1371","volume":"8","author":[{"given":"Santosh K.","family":"Panda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin C.","family":"Tupperwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyajit","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineeta","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balachandran","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,5,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000.","volume":"348","author":"GS Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.200510-1604OE","article-title":"The last 100 years of sepsis.","volume":"173","author":"JL Vincent","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity.","volume":"124","author":"S Akira","year":"2006","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity.","volume":"34","author":"T Kawai","year":"2011","journal-title":"Immunity"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ddmec.2007.10.004","article-title":"Mechanisms of sepsis and insights from clinical trials.","volume":"4","author":"N Seam","year":"2007","journal-title":"Drug Discov Today Dis Mech"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"RS Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/35100529","article-title":"Toll-like receptors and innate immunity.","volume":"1","author":"R Medzhitov","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation.","volume":"8","author":"DM Mosser","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"34698","DOI":"10.1074\/jbc.M405444200","article-title":"A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4.","volume":"279","author":"MN Kennedy","year":"2004","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4049\/jimmunol.173.2.1166","article-title":"TLR4 is the signaling but not the lipopolysaccharide uptake receptor.","volume":"173","author":"S Dunzendorfer","year":"2004","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1084\/jem.20031076","article-title":"Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.","volume":"198","author":"S Akashi","year":"2003","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11095-008-9571-x","article-title":"Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.","volume":"25","author":"CG Leon","year":"2008","journal-title":"Pharm Res"},{"key":"ref13","first-page":"642462","article-title":"Novel insights for systemic inflammation in sepsis and hemorrhage.","volume":"2010","author":"B Cai","year":"2010","journal-title":"Mediators Inflamm"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1517\/13543784.9.7.1651","article-title":"Anti-inflammatory therapies in sepsis and septic shock.","volume":"9","author":"BD Freeman","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1073\/pnas.0808146106","article-title":"Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4.","volume":"106","author":"T Roger","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.20071990","article-title":"TLR4-induced IFN-gamma production increases TLR2 sensitivity and drives Gram-negative sepsis in mice.","volume":"205","author":"S Spiller","year":"2008","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.4049\/jimmunol.179.9.6107","article-title":"TLR4\/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock.","volume":"179","author":"B Daubeuf","year":"2007","journal-title":"J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"568396","DOI":"10.1155\/2010\/568396","article-title":"Toll-like receptor 4 modulation as a strategy to treat sepsis.","volume":"2010","author":"X Wittebole","year":"2010","journal-title":"Mediators Inflamm"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm1589","article-title":"Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.","volume":"13","author":"H Kanzler","year":"2007","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1084\/jem.20091236","article-title":"Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner.","volume":"206","author":"A Cauwels","year":"2009","journal-title":"J Exp Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1126\/science.1188635","article-title":"SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis.","volume":"328","author":"P Puneet","year":"2010","journal-title":"Science"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"993","DOI":"10.4049\/jimmunol.178.2.993","article-title":"Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivo.","volume":"178","author":"S Knapp","year":"2007","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nature01023","article-title":"Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.","volume":"419","author":"VN Bochkov","year":"2002","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/nm1654","article-title":"Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes.","volume":"13","author":"AJ Melendez","year":"2007","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1128\/IAI.72.1.398-407.2004","article-title":"Both free-living and parasitic nematodes induce a characteristic Th2 response that is dependent on the presence of intact glycans.","volume":"72","author":"S Tawill","year":"2004","journal-title":"Infect Immun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.20102049","article-title":"Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).","volume":"208","author":"AC Bulua","year":"2011","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-2478(02)00225-0","article-title":"Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro.","volume":"85","author":"MG Nair","year":"2003","journal-title":"Immunol Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ni.1920","article-title":"The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection.","volume":"11","author":"T Satoh","year":"2010","journal-title":"Nat Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature05746","article-title":"Chitin induces accumulation in tissue of innate immune cells associated with allergy.","volume":"447","author":"TA Reese","year":"2007","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury.","volume":"73","author":"CG Lee","year":"2011","journal-title":"Annu Rev Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene.","volume":"282","author":"A Poltorak","year":"1998","journal-title":"Science"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","article-title":"Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.","volume":"162","author":"K Hoshino","year":"1999","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages.","volume":"3","author":"S Gordon","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/346043","article-title":"Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.","volume":"187","author":"A Verbon","year":"2003","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1023\/A:1022528912387","article-title":"Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.","volume":"23","author":"CA Spek","year":"2003","journal-title":"J Clin Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.4049\/jimmunol.164.10.5439","article-title":"Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis.","volume":"164","author":"CW Frevert","year":"2000","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI20762","article-title":"Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.","volume":"113","author":"G Meng","year":"2004","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e6503","DOI":"10.1371\/journal.pone.0006503","article-title":"The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock.","volume":"4","author":"YI Jeong","year":"2009","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.","volume":"166","author":"PQ Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.CCM.0000105423.06091.8E","article-title":"Mediator modulation therapy of severe sepsis and septic shock: does it work?","volume":"32","author":"R Phillip Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.2174\/138161206778743484","article-title":"\u2018Toll\u2019 gates for future immunotherapy.","volume":"12","author":"KJ Ishii","year":"2006","journal-title":"Curr Pharm Des"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"14978","DOI":"10.1073\/pnas.0809784106","article-title":"Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB.","volume":"106","author":"C Porta","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.4049\/jimmunol.1001952","article-title":"Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells.","volume":"186","author":"OM Pena","year":"2011","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1074-7613(00)80014-X","article-title":"Other functions, other genes: alternative activation of antigen-presenting cells.","volume":"10","author":"S Goerdt","year":"1999","journal-title":"Immunity"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","article-title":"Macrophage polarization comes of age.","volume":"23","author":"A Mantovani","year":"2005","journal-title":"Immunity"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm1451","article-title":"Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.","volume":"12","author":"RM Anthony","year":"2006","journal-title":"Nat Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2567.2008.02826.x","article-title":"The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo.","volume":"125","author":"O Atochina","year":"2008","journal-title":"Immunology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1128\/IAI.73.1.166-173.2005","article-title":"Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.","volume":"73","author":"S Donnelly","year":"2005","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.4049\/jimmunol.167.4.2193","article-title":"Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B.","volume":"167","author":"BA Butcher","year":"2001","journal-title":"J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijpara.2003.12.005","article-title":"The NF-kappaB signaling pathway: immune evasion and immunoregulation during toxoplasmosis.","volume":"34","author":"S Shapira","year":"2004","journal-title":"Int J Parasitol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1126\/science.1094351","article-title":"A toll-like receptor that prevents infection by uropathogenic bacteria.","volume":"303","author":"D Zhang","year":"2004","journal-title":"Science"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.4049\/jimmunol.0800531","article-title":"Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cells.","volume":"182","author":"Y He","year":"2009","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.173.4.2699","article-title":"A secreted protein from the human hookworm necator americanus binds selectively to NK cells and induces IFN-gamma production.","volume":"173","author":"GC Hsieh","year":"2004","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1086\/599090","article-title":"Alternatively activated and immunoregulatory monocytes in human filarial infections.","volume":"199","author":"S Babu","year":"2009","journal-title":"J Infect Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.micinf.2006.05.003","article-title":"Human bancroftian filariasis: immunological markers of morbidity and infection.","volume":"8","author":"AK Satapathy","year":"2006","journal-title":"Microbes Infect"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1128\/IAI.72.4.2123-2130.2004","article-title":"Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression.","volume":"72","author":"KA Ryan","year":"2004","journal-title":"Infect Immun"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis.","volume":"5","author":"JT Pesce","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.","volume":"458","author":"BS Park","year":"2009","journal-title":"Nature"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/bioinformatics\/bti315","article-title":"Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites.","volume":"21","author":"AT Laurie","year":"2005","journal-title":"Bioinformatics"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.diagmicrobio.2007.12.013","article-title":"Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen.","volume":"61","author":"N Tupperwar","year":"2008","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1002717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T18:54:27Z","timestamp":1687460067000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1002717"}},"subtitle":[],"editor":[{"given":"Thomas A.","family":"Wynn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1002717","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716497896.792002851","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}